Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-05-26
DOI
https://doi.org/10.1111/jdv.20691
Citations
1
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
1.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority

Sergio Vañó‐Galván, David Saceda‐Corralo
1 citations
Journal of the European Academy of Dermatology and Venereology
Hair Growth and Disorders
1.84
article

Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority

Sergio Vañó‐Galván, David Saceda‐Corralo
article en
1 citations

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and VenereologyVol. 39(6)
Universidad de Alcalá (ES), Instituto Cajal (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES)
Pfizer
Zero hunger
Openalex Percentile: Top 17%
Hair Growth and Disorders
1.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.